This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The pharma industry spends more on lobbying than any other industry, having shelled out $314 million across about 1,600 lobbyists in 2021 , spending almost three times the amount of the next biggest spender in the health sector. These hospitals spent $116 million on federal lobbying in 2021. Innovation and Competition Act.
Increasingly, it’s a competitive differentiator – and it can help drive clinical improvements. Likewise, as of January 2021 hospitals must share prices online and provide plain-language descriptions of available services. That means providing more patient-friendly terminology is more than just a compliance checkbox.
The Inflation Reduction Act’s health insurance subsidies and drug pricing reforms will improve health care affordability for Americans but won’t do a damn thing for our overall healthcare costs, which will keep rising. A staggering 85% of healthcare costs in the U.S. Finally, there are healthcare administrative costs.
But increased competition is on the horizon. Competition starts to heat up. In a case filed in California in 2021, Molina Healthcare claimed Jazz Pharmaceuticals engaged in a “comprehensive anticompetitive scheme to suppress generic competition for Xyrem,” abused the REMS program, and “engaged in sham patent litigation.”.
Have you found that your 2021 strategies for engaging with your customers aren’t working as expected? In 2020 most pharmaceutical companies had to shift strategies to reach their customers via multi-channel, digital platforms, with hope that by 2021, everything would be back to normal. But the reality is, 2021 is far from that.
Oh no, 2021 has started and our plan is already outdated! In 2020 most pharmaceutical companies continued their strategic planning as if by 2021 everything would be back to normal. But the reality is, 2021 is far from that. We are changing our habits and your healthcare stakeholders aren’t any different. Sounds familiar?
It’s often stated – mostly without reference to data – that the environment for innovative launches is more competitive now than it ever has been. Continued competitive intensity. The first in class launches barely have time to establish before they face competition, and then the competition keeps on coming.
Sixty percent of employees in a recent survey reported experiencing healthcare cost increases that outpaced inflation in the past three years, and 63 percent expect that trend to continue, signaling potential cost challenges in the future. Right now, annual raises are being neutralized by increasing healthcare insurance premiums.
And the findings are clear: Without a positive, up-to-date, and lively online presence, healthcare practices are falling behind and losing patients to the competition. Tune in to discover: How the travel industry revolutionized consumer insights and data collection and the path for healthcare to follow suit.
In the dynamic world of healthcare marketing, understanding your audience and optimizing your strategies are key to staying ahead of the competition. Practices can use healthcare data analytics to gain insights that can transform their marketing efforts in the digital age.
Healthcare is a rapidly changing industry, and if you want to stay ahead of the curve, you’ll need to adopt some cutting-edge marketing strategies. As 2023 approaches, there are several strategies you can adopt to improve your healthcare marketing efforts and grow your practice. 6 Medical Marketing Strategies to Adopt in 2023.
Struggling with burnout while maintaining high-quality healthcare services that patients love? Tune in to our latest podcast as Lee Aase, founder of HELPCare, LLC, shares how he transitioned from his pioneering social media work at Mayo Clinic to lead an innovative membership-based direct-to-patient healthcare business.
The 2021 NextGen Pharma Content , taking place on March 23-24 , will bring together content creators, marketers, and communications/PR practitioners to learn how to build trust and earn loyalty with customers to achieve a positive emotional connection with your brand. REGISTER TODAY!
healthcare payers and providers are consolidating at a dizzying clip as they seek to gain market share, increase access to care and secure clinical control to improve health outcomes. CVS’ bid for Oak Street is in keeping with nearly two decades of evolution toward becoming an integrated payer and provider.
In this episode of the Healthcare Leadership Podcast , host Jennifer Thompson engages in a dynamic discussion with Matthew Davis, Director of Channel Partnerships at Press Ganey. Together, they explore the latest 2021 Consumer Experience Trends in Healthcare report insights.
Many industries have undergone a rapid revolution during 2020, especially healthcare. As a medical sales professional looking ahead to 2021, now more than ever it is imperative to evaluate your strategy for the new year. Here are 21 tips to grow your medical sales business in 2021: 21 – Understand Pain Points.
This is updated strategy replaces the original five-year strategy, which was developed to cover from 2021 to 2025 (EMANS 2025). A draft joint EU network strategy to 2028 has been published by the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA).
Reading time: 7 minutes As we all look to 2021, what are the pharmaceutical industry trends to build into your life sciences marketing strategy? But today, the need to satisfy patients, providers, payers, regulatory agencies, and shareholders alike — while staying ahead of the competition — takes the right technologies at the right time. .
Healthcare price transparency continues to grow, with health insurers required to release cost-sharing estimates beginning in 2022. What’s new for healthcare price transparency in 2021 ? The American healthcare system is ushering in a new era of health cost transparency. Why is price transparency important in healthcare?
Face-to-face interactions with healthcare providers or HCPs are declining. Leverage intelligence for immediate insight into competitive data that helps sales teams create stronger targeting strategies and personalized, highly contextual customer experiences. Trend 2: Evolved commercial strategies and models. Does such a system exist?
As healthcare practices strive to navigate the complexities of patient needs and preferences, the importance of fostering robust patient engagement strategies cannot be overstated. The Importance of Patient Engagement Personalization for patients is a key driver of improved healthcare outcomes.
Following the acquisition of Dialog Solutions as part of the ProQuest M&A in December 2021, Dialog Solutions products and services will be folded into the Clarivate portfolio of offerings for Life Sciences & Healthcare. Today, the Dialog Solutions brand has been integrated into Clarivate.
Amazon has accelerated its expansion into the healthcare sector with an all-cash deal to acquire One Medical, a US group that provides virtual and in-person primary care services using a subscription fee model. “We look forward to innovating and expanding access to quality healthcare services, together.”
billion in 2021, with a compounded annual growth rate (CAGR) of 3.1% What really matters are the orthopedic medical device trends that are already shaping the healthcare industry. Advancements in medical technology will always be a favorite topic of discussion when analyzing the healthcare sector. from 2022 to 2030.
Increasing competition for talent, as well as the uncertainty of remote versus in-person workspaces, impacts new hire engagement. According to Gallup’s monthly employment trends, the percentage of employees working from home full-time (25%) and some of the time (20%) remained steady between July and September 2021. EcoVadis.com.
ON 11 JANUARY 2022, Regulation (EU) 2021/2282 on health technology assessment (HTA) came into force. border healthcare, specifically by repealing Article 15, which originally laid down the modalities and principles for co-operation between Member States in assessing new health technologies. governmental healthcare organisations.
By leveraging data analytics to optimize and expand telemedicine capabilities, payers can effectively address the critical challenge of extending quality healthcare to underserved areas while managing costs. Long wait times can be frustrating for patients, but telemedicine can facilitate quick and easy access to healthcare.
The No Surprises Act and Transparency in Coverage Rule The past two years have been monumental for healthcare transparency and reporting regulations. The second protection from surprise bills is for non-emergent settings when a patient receives care from an out-of-network healthcare provider while at an in-network facility.
Healthcare prices in the U.S. Complying with the regulations won’t be enough for healthcare delivery organizations that want to thrive in this new, more transparent environment. While price transparency does present new, interesting challenges to healthcare delivery organizations, it also opens the door for new growth opportunities.
Vazkepa is a highly purified omega-3 fatty acid formulation that was approved for this indication by the Medicines and Healthcare products Regulatory Agency (MHRA) last year. In the REDUCE-IT study, which enrolled 8,179 statin-treated adult patients with moderately elevated triglyceride levels who were followed for a median duration of 4.9
The Biosimilars Forum has hailed 2022 as a watershed year that could create a more competitive U.S. previously seen when Biocon and Viatris launched the interchangeable insulin biosimilar SEMGLEE, a biosimilar of Sanofi’s blockbuster long-acting insulin Lantus, in 2021 for a 65% discount over its equivalent.
The latest market study report from the Competition Bureau has provided recommendations to health care providers (HCPs) on how to improve the ways they work within Canada’s public health system. The new report states that digital health care is not being used to its full potential in Canada.
Approximately 30% of global data volume is generated by the healthcare industry and it will continue to expand with a compound annual growth rate predicted to reach 36% by 2025, according to research by RBC Capital Markets. billion in 2021 to $9.23 I believe huge opportunities await organisations that properly leverage their data.”.
Over the past year, the healthcare industry has widely embraced the use of telemedicine and digital health platforms largely as a response to the COVID-19 Public Health Emergency. The healthcare sector is the most vulnerable to cyberattacks and data breaches, accounting for nearly half of all data breaches.
What can Healthcare and Life Sciences businesses and investors anticipate for the healthcare industry in 2022? We asked our team five direct questions about innovations in healthcare, life sciences, and digital health in the coming year: What healthcare trends or opportunities are you most excited about?
As we mentioned earlier, nearly three in four doctors now work for a hospital, health system, or corporate entity, according to an April 2022 survey from Avalere Health —a 7% increase from 2021 and a nearly 20% jump from 2019. This step is particularly crucial in an era where new competition enters the market every day.
Unsurprisingly, the US FDA has reported a noticeable increase in the number of submissions that use AI/machine learning (ML) components in recent years; in 2021, they received more than 100 submissions wherein AI use was reported. In 2022, the AI-fuelled pipeline reportedly expanded at an annual rate of almost 40%.
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has also since granted the Great Britain marketing authorisation of Lupkynis to treat adults with active LN. Overall, Aurinia’s Lupkynis is expected to face tough competition from Benlysta in LN, which received FDA approval in December 2020 and EMA approval in May 2021.
The DHSC said that this was an exceptional change, reflecting the rapid growth in sales in 2021 driven in part by COVID-19. What’s missing from this table, because it’s not published in the 2019 VPAS agreement annexe, are the original forecasted payment percentages for 2021, 2022, and 2023. Annual payment percentage.
In February 2021, Ohio moved to a single pharmacy benefit manager system , hiring Gainwell Technologies (previously DXC technologies) to manage all PBM functions. Kentucky awarded Medicaid pharmacy benefits contract to MedImpact went into effect in July 2021. Clarivate Medicaid profiles as of September 2021).
More than just a buzzword, healthcare price transparency has become a pivotal tool for helping providers negotiate better contracts with payers. Understanding healthcare price transparency Historically, healthcare contracting, billing practices, and prices have been shrouded in mystery.
2021 launched a new era for healthcare price transparency. In January 2021, the Healthcare Price Transparency Act went into effect, requiring hospitals to publish their cash pay rates and rates negotiated with health insurance companies.
High rates of obesity place a major burden on healthcare systems as the condition is associated with many major health complications like type 2 diabetes, hypertension, non-alcoholic fatty liver disease, and other bodily dysfunctions. In the US, obesity care is estimated at to cost $147 billion in healthcare spending annually.
In a fiercely competitive U.S. healthcare provision landscape, integrated delivery networks, or IDNs, are differentiating their offerings by adding outpatient treatment centers, pursuing National Cancer Institute designations and investing in value-based care. Christopher Silva, Senior Healthcare Research Analyst.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content